Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Autologous CIK cell immunotherapy in patients with renal cell carcinoma after radical nephrectomy.

Clinical & developmental immunology - 1 Jan 2013

Zhang Yajing, Wang Jin, Wang Yao, Lu Xue-Chun, Fan Hui, Liu Yang, Zhang Yan, Feng Kai-Chao, Zhang Wen-Ying, Chen Mei-Xia, Fu Xiaobing, Han Wei-Dong

Abstract excerpt

OBJECTIVE: To evaluate the efficacy of autologous cytokine-induced killer (CIK) cells in patients with renal cell carcinoma (RCC). METHODS: 20 patients diagnosed with TNM stage I or II RCC were randomly divided into two groups, a CIK cell treatment group and a control group. The endpoint was progression-free survival (PFS) evaluated by Kaplan-Meier analyses. RESULTS: CD3(+), CD3(+)/CD8(+), CD3(+)/CD4(+), and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Renal Cell
Share to Cell Culture Techniques

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Kidney Neoplasms

Share to Lymphocyte Subsets

Share to Nephrectomy

Share to Tomography, X-Ray Computed

Share to Transplantation, Homologous

Source

Open in PubMed Open full text

Identifiers

PMID: 24382970
DOI: 10.1155/2013/195691
PMCID: PMC3872096

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Autologous CIK cell immunotherapy in patients with renal cell carcinoma after radical nephrectomy.PMID 24382970Read ↗

Evolution of cell therapy for renal cell carcinomaSemantic proximity Read ↗

Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer.Semantic proximity Read ↗

Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challengesSemantic proximity Read ↗

Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.Semantic proximity Read ↗

Chimeric antigen receptor-natural killer cell therapy: a new force in intrinsic immunotherapy for cancer treatmentSemantic proximity Read ↗

The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study.Semantic proximity Read ↗

CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedsideSemantic proximity Read ↗

Immunotherapy with cytokine-induced killer cells as an adjuvant treatment for advanced gastric carcinoma: a retrospective study of 165 patients.Semantic proximity Read ↗

Effectiveness of allogeneic CD3AK cells on transplanted human renal cell cancer in mice with severe combined immune deficiency.Semantic proximity Read ↗

Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation.Semantic proximity Read ↗

Chemotherapy, Immunotherapy, and Surgery Should be Optimal Treatment Choices of Metastatic Sarcomatoid Renal Cell CarcinomaSemantic proximity Read ↗

The phenotype of ex vivo generated cytokine-induced killer cells is associated with overall survival in patients with cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.